Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

HSV-2 ΔgD elicits FcγR-effector antibodies that protect against clinical isolates.

Petro CD, Weinrick B, Khajoueinejad N, Burn C, Sellers R, Jacobs WR Jr, Herold BC.

JCI Insight. 2016 Aug 4;1(12). pii: e88529.

2.

The Vaginal Acquisition and Dissemination of HIV-1 Infection in a Novel Transgenic Mouse Model Is Facilitated by Coinfection with Herpes Simplex Virus 2 and Is Inhibited by Microbicide Treatment.

Seay K, Khajoueinejad N, Zheng JH, Kiser P, Ochsenbauer C, Kappes JC, Herold B, Goldstein H.

J Virol. 2015 Sep;89(18):9559-70. doi: 10.1128/JVI.01326-15. Epub 2015 Jul 8.

3.

Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease.

Petro C, González PA, Cheshenko N, Jandl T, Khajoueinejad N, Bénard A, Sengupta M, Herold BC, Jacobs WR.

Elife. 2015 Mar 10;4. doi: 10.7554/eLife.06054.

Supplemental Content

Loading ...
Support Center